[Venous thromboembolism prophylaxis in major orthopaedic surgery: A multicenter, prospective, observational study]

Acta Orthop Traumatol Turc. 2008 Nov-Dec;42(5):322-7. doi: 10.3944/aott.2008.322.
[Article in Turkish]

Abstract

Objectives: We investigated risk factors for venous thromboembolism (VTE), prophylaxis measures employed, and incidence of symptomatic deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing major orthopaedic surgery (MOS).

Methods: An open, multicenter, prospective, observational study was conducted in 21 medical centers, comprising 899 patients. Of these, 316 patients (35.2%) underwent total hip arthroplasty (THA), 328 patients (36.5%) underwent total knee arthroplasty (TKA), and 255 patients (28.4%) underwent surgery for hip fractures (HF). Pharmacologic prophylaxis was employed in all the patients.

Results: Risk factors for VTE were seen in 73.2% of the patients, the most common being obesity (72%) and prolonged immobilization (36.3%). Low-molecular-weight heparin (91.1%) and fondaparinux (8.9%) were used for prophylaxis, which was short-term in 273 patients (30.4%) and long-term in 626 patients (69.6%). Mechanical prophylaxis was performed with compression stockings in 610 patients (67.9%) and by intermittent pneumatic compression in 67 patients (7.5%). During three-months of follow-up, symptomatic DVT and PE were seen in eight (0.9%) and four patients (0.4%), respectively. Mortality occurred in 10 patients (1.1%). Complications of major and minor bleeding were seen in eight (0.9%) and 40 (4.5%) patients, respectively.

Conclusion: Effective VTE prophylaxis is associated with low risk of clinically apparent DVT and PE in MOS.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use*
  • Arthroplasty, Replacement, Hip / adverse effects
  • Arthroplasty, Replacement, Knee / adverse effects
  • Female
  • Fondaparinux
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Hip Fractures / surgery
  • Humans
  • Immobilization / adverse effects
  • Male
  • Middle Aged
  • Obesity / complications
  • Orthopedic Procedures / adverse effects*
  • Polysaccharides / therapeutic use
  • Prospective Studies
  • Pulmonary Embolism / epidemiology
  • Pulmonary Embolism / mortality
  • Pulmonary Embolism / prevention & control*
  • Risk Factors
  • Venous Thromboembolism / epidemiology
  • Venous Thromboembolism / mortality
  • Venous Thromboembolism / prevention & control*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Polysaccharides
  • Fondaparinux